Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response (vol 90, pg 568, 2011)

被引：0
|
作者：
Lewis, J. P.
Fisch, A. S.
Ryan, K.
O'Connell, J. R.
Gibson, Q.
Mitchell, B. D.
Shen, H.
Tanner, K.
Horenstein, R. B.
Pakzy, R.
Tantry, U. S.
Bliden, K. P.
Gurbel, P. A.
Shuldiner, A. R.
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：751 / 751
页数：1
相关论文
共 50 条
  • [41] Paraoxonase1 192 (PON1 192) Gene Polymorphism and Serum Paraoxonase Activity in Panic Disorder Patients
    Atasoy, Hande
    Gulec-Yilmaz, Seda
    Ergen, Arzu
    Gormus, Uzay
    Kucukhuseyin, Ozlem
    Dalan, Burak
    Ol, Kevser Kusat
    Ogut, Dicle Bilge
    Gulec, Huseyin
    Cetin, Bugra
    Timirci-Kahraman, Ozlem
    Ormeci, Burcu
    Ucunoglu, Nazli
    Gultekin, Guldal Inal
    Isbir, Turgay
    IN VIVO, 2015, 29 (01): : 51 - 54
  • [42] Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma
    Carmen Martínez
    José A Molina
    Hortensia Alonso-Navarro
    Félix J Jiménez-Jiménez
    José AG Agúndez
    Elena García-Martín
    BMC Neurology, 10
  • [43] The paraoxonase 1 (PON1) gene polymorphisms in coronary artery disease in the southeastern Turkish population
    Hazar, Abdussemet
    Dilmec, Fuat
    Goz, Mustafa
    Kocarslan, Aydemir
    Aydin, Mehmet Salih
    Demirkol, Abbas Heval
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2011, 41 (05) : 895 - 902
  • [44] Paraoxonase-1 is a major determinant of clopidogrel efficacy (vol 17, pg 110, 2011)
    Bouman, Heleen J.
    Schoemig, Edgar
    van Werkum, Jochem W.
    Velder, Janna
    Hackeng, Christian M.
    Hirschhaeuser, Christoph
    Waldmann, Christopher
    Schmalz, Hans-Guenther
    ten Berg, Jurrien M.
    Taubert, Dirk
    NATURE MEDICINE, 2011, 17 (09) : 1153 - 1153
  • [45] Genetic polymorphisms in the paraoxonase 1 (PON1) gene and the risk of coronary heart disease.
    Sanghera, DK
    Saha, N
    Kamboh, MI
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A210 - A210
  • [46] Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - Connection with inflammation
    Krzystek-Korpacka, Malgorzata
    Boehm, Dorota
    Matusiewicz, Malgorzata
    Diakowska, Dorota
    Grabowski, Krzysztof
    Gamian, Andrzej
    CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) : 804 - 811
  • [47] Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice
    Rozenberg, O
    Rosenblat, M
    Coleman, R
    Shih, DM
    Aviram, M
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 34 (06) : 774 - 784
  • [48] Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel
    Halim, Hasseri
    Pinkaew, Decha
    Chunhacha, Preedakorn
    Sinthujaroen, Patuma
    Thiagarajan, Perumal
    Fujise, Ken
    PLOS ONE, 2019, 14 (06):
  • [49] HDL - ASSOCIATED PARAOXONASE 1 (PON1) ATTENUATES MACROPHAGE FOAM CELL FORMATION AND ATHEROGENESIS
    Aviram, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [50] S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity
    Rozenberg, Orit
    Aviram, Michael
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (02) : 492 - 498
12345